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Abstract We consider an age-structured epidemic model with two basic pub-
lic health interventions: (i) identifying and isolating symptomatic cases, and
(ii) tracing and quarantine of the contacts of identified infectives. The dy-
namics of the infected population are modeled by a nonlinear infection-age-
dependent partial differential equation, which is coupled with an ordinary dif-
ferential equation that describes the dynamics of the susceptible population.
Theoretical results about global existence and uniqueness of positive solutions
are proved. We also present two practical applications of our model: (1) we
assess public health guidelines about emergency preparedness and response in
the event of a smallpox bioterrorist attack; (2) we simulate the 2003 SARS
outbreak in Taiwan and estimate the number of cases avoided by contact trac-
ing. Our model can be applied as a rational basis for decision makers to guide
interventions and deploy public health resources in future epidemics.
Keywords age since infection · epidemic disease · quarantine · SARS ·
smallpox
Mathematics Subject Classification (2000) 92B05 · 35Q92 · 37N25
1 Introduction
Our aim is to develop a model to assess the effectiveness of two public health
interventions in controlling epidemic outbreaks: (i) identifying and isolating
symptomatic cases, and (ii) tracing of their contacts, followed by isolation,
quarantine, or vaccination. Our model is applicable to general epidemics for
which quarantine or vaccination are available as control measures. In many
cases, there are two alternatives for such controls, namely targeted control or
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mass control. Isolation of symptomatic cases is important in controlling infec-
tious diseases, but also important may be the vaccination and quarantine of
traced contacts of known infectives. Contact tracing is especially important
when there is a lack of rapid diagnostic methods, as was in the case of SARS
(Glasser et al 2011).
Ordinary differential equation models were used in modeling SARS, and in
particular to investigate the impact of quarantining asymptomatic infectives
(Hethcote et al 2002; Wang and Ruan 2003; Hsieh et al 2004; Gumel et al 2004;
Nishiura et al 2004; Fraser et al 2004; Day et al 2006; Hsu and Hsieh 2006;
Arino et al 2006; Feng et al 2007, 2009, 2011). A thorough review of many of
these works has been provided in (Bauch et al 2005). The article points out
that the nonlinearity of the rate of quarantining undiagnosed cases is required
to be taken into account. In this paper, we use a partial differential equation
model with a variable of disease age (or age since infection), with nonlinear
rates of contact tracing infectives and quarantining susceptibles dependent on
the rate of identifying symptomatic cases.
In the smallpox application, our model applies to the ring vaccination
strategy which is believed to be the reason for smallpox eradication. Vari-
ous methods have been developed to evaluate public health control strategies
for smallpox, such as stochastic models (Mu¨ller et al 2000; Meltzer et al 2001;
Halloran et al 2002; Eichner 2003; Kretzschmar et al 2004; Vidondo et al 2012),
and ordinary differential equation models (Kaplan et al 2003, 2002; Valle et al
2005).
Although some of the previous work include the varying levels of trans-
mission ability and symptom scores in different disease stages, there is less
work about smallpox control that takes continuous disease age into consid-
eration. Webb et al. apply age structured epidemic models to investigate
isolation strategy and school closings in the spread of H1N1 (Webb et al
2010). Inaba et al. develop a series of multistate class age structured epi-
demic systems with isolation rate as the only intervention (Inaba and Nishiura
2008). Fraser et al. establish an infection age-structured model that esti-
mates the effectiveness of isolation and contact tracing in the control of epi-
demic diseases with a formulation different from ours (Fraser et al 2004). Our
model is aimed to take into consideration several key features about disease
transmission and public health interventions at the same time: (i) continu-
ous infection age; (ii) infection-age-dependent case isolation rate; (iii) contact
tracing/quarantine/vaccination rates that depend on diagnosis rate of symp-
tomatic cases; (iv) variation of susceptible population due to infection and
contact tracing/quarantine/vaccination.
We present the general model in Section 2. In Section 3, the preliminary
results about the solutions to the general problem are stated. In Section 4,
we illustrate more analysis results for the specific problem, and we provide
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all of the proofs in Appendix. Our model application to smallpox, as well as
practical interpretations of the model parameters, are demonstrated in Section
5. Then we investigate the effectiveness of contact tracing strategies which were
implemented in control of 2003 SARS in Taiwan as the second application in
Section 6.
2 A Logistic Age-Dependent Epidemic Model
First of all, we clarify the definitions of the three intervention strategies con-
sidered in the model: (1) isolation is the process by which infected people (all
of whom are symptomatic) are prevented from infecting susceptible ones; (2)
contact tracing is the process of identifying people who may have been infected
by exposure to (or contact with) an infectious person; (3) quarantine is the
process of isolating these people, called contacts (none of whom is yet symp-
tomatic, and many are not even infected)1. The conduct of quarantine can be
divided into two types: (i) quarantine close contacts of identified cases, and (ii)
quarantine large groups of people (such as residents in residential complexes,
workers in a workplace, students in schools, etc). Our model focuses on the (i)
type quarantine, which is conducted as a consequence of tracing close contacts
of infected individuals.
Before introducing the main model, we introduce the notations as follows:
(N.1) For 0 < M 6 ∞, let L1 := L1 ([0,M] ;R), L1+ := L1 ([0,M] ;R+) which
is the positive cone in L1. M denotes the maximum disease age in the
model.
(N.2) For 0 < T 6∞, denote CT := C
(
[0, T ] ;L1
)
with the supremum norm:
‖l‖CT := sup
06t6T
‖l (t)‖L1 , for l ∈ CT . Let CT,+ := C
(
[0, T ] ;L1+
)
which
is the positive cone in CT .
The basic assumptions are as follows:
(A.1) Let T ∈ (L1)∗ with norm ‖T ‖∞, and we assume T (L1+) ⊆ R+.
(A.2) B,Q : L1 → R be globally Lipschitz continuous functions with Lipschitz
constants |B| and |Q|. Moreover, we assume B (L1+) ⊆ R+ andQ (L1+) ⊆
R+.
(A.3) B (0) = 0, Q (0) = 0.
For t > 0, a ∈ [0,M], the formal model is:
1 Thanks to J. Glasser at Centers for Disease Control and Prevention for kindly providing
the definitions.
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∂
∂t
i (a, t) +
∂
∂a
i (a, t) = −µ (a) i (a, t)︸ ︷︷ ︸
isolation of symptomatic
individuals with infection
age a
−T (i (·, t)) i (a, t)︸ ︷︷ ︸
tracing of contacts
with infection age a
d
dt
S (t) = −B (i (·, t))S (t)︸ ︷︷ ︸
infection of susceptibles
−Q (i (·, t))S (t)︸ ︷︷ ︸
quarantine of contacts
that are susceptible
i (0, t)︸ ︷︷ ︸
infectives with
infection age 0
= B (i (·, t))S (t)︸ ︷︷ ︸
rate of new infections
i(a, 0) = i0(a) ∈ L1 [0,M]
S(0) = S0 ∈ R+
(2.1)
where i(a, t) is the infected population density at infection age a at time t, and
S(t) is the susceptible population at time t, µ(a) is the rate of isolating symp-
tomatic cases those are at disease age a. If we denote i (·, t) as the infected
population density function at time t, then B (i (·, t)) represents the infection
transmission rate, T (i (·, t)) represents the isolation rate of infected individu-
als due to contact tracing at time t, and Q (i (·, t)) represents the quarantine
rate of susceptible contacts as the consequence of contact tracing.
Solving for S (t) from the second equation in (2.1), we can simplify the
problem into an age-dependent population dynamics model for i (a, t):
∂
∂t
i (a, t) +
∂
∂a
i (a, t) = −µ (a) i (a, t)− T (i (·, t)) i (a, t)
i (0, t) = S0B (i (·, t)) e−
∫ t
0
B(i(·,s))+Q(i(·,s))ds
i(a, 0) = i0(a)
(2.2)
In the following context, we denote i (t)(a) := i (a, t); then i ∈ CT means
i(t) ∈ L1, for t ∈ [0, T ]. We also refer the solutions of the age-dependent prob-
lem as l (t)(a) := i (a, t), where l ∈ CT . Next we will generalize the problem to
a formulation of age-dependent population dynamics. We introduce the aging
and birth functions:
(1) Let G : L1 → L1 be the aging function.
(2) For 0 < T 6 ∞, let F : CT = C
(
[0, T ] ;L1
) → C ([0, T ] ;R) be the birth
function.
Let 0 < T 6 ∞, let t ∈ [0, T ] and l ∈ CT , the general age-dependent
problem is as follows:
∂
∂t
l (t)(a) +
∂
∂a
l (t)(a) = G(l (t))(a) , a.e. a ∈ [0,M]
l (t)(0) = (F (l))(t)
l (0)(a) = φ (a) , a.e. a ∈ [0,M]
(2.3)
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However, the equation system in (2.3) is not well defined for solutions that
are not continuously differentiable with respect to both variables. We are thus
led to the following formulation of age-dependent population dynamics as in
(Webb 1985): let 0 < T 6∞, and let l ∈ CT satisfy:
lim
h→0+
∫ M
0
∣∣h−1 [l (t+ h)(a+ h)− l (t)(a)]−G(l (t))(a)∣∣ da = 0
lim
h→0+
∫ h
0
|l (t+ h)(a)− (F (l))(t)| da = 0
l (0)(a) = φ (a) , a.e. a ∈ [0,M]
(2.4)
where we let l (t+ h)(a+ h) = 0 if a+ h > M.
3 Preliminary Results
In this section, we will present results about local existence and uniqueness of
the solutions to the age-dependent problem (2.4) with the following assump-
tions on the aging and birth functions:
(H.1) G : L1 → L1, there is an increasing function c1 : [0,∞) → [0,∞) such
that ‖G (φ1)−G (φ2)‖L1 ≤ c1 (r) ‖φ1 − φ2‖L1 for all φ1, φ2 ∈ L1 such
that ‖φ1‖L1 , ‖φ2‖L1 ≤ r.
(H.2) There is a function c2 : [0,∞) × [0,∞) → [0,∞), which is increasing
and continuous w.r.t. both variables. Then for all T > 0, F : CT →
C ([0, T ] ;R), for any 0 ≤ t ≤ T and r > 0, we have
|(F (φ1))(t)− (F (φ2))(t)| 6 c2 (r, t) sup
06s6t
‖φ1 (s)− φ2 (s)‖L1
for all φ1, φ2 ∈ CT such that ‖φ1‖CT , ‖φ2‖CT ≤ r.
We state theorems about local existence and uniqueness of the solutions below.
The proofs (they can be found in the Appendix) are different from those in
(Webb 1985), since our assumption of the birth function F is different.
Theorem 31 Let (H.1) and (H.2) hold and let φ ∈ L1. There exists T > 0
and l ∈ CT such that l is a solution of (2.4) on [0, T ]. Furthermore, there is
a unique solution of (2.4) on [0, T ].
We introduce the definition of maximal interval of existence as in (Webb 1985):
Definition 1 Let φ ∈ L1. Denote [0, Tφ) as the maximal interval of existence
of the solution of (2.4), is the maximal interval with the property that if
0 < T < Tφ, there exist l ∈ CT such that l is a solution of (2.4) on [0, T ].
With additional assumptions as stated below, we will prove the positivity of
the solutions.
(H.3) F (CT,+) ⊆ C ([0, T ] ;R+)
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(H.4) There is an increasing function c3 : [0,∞) → [0,∞) such that if r > 0
and φ ∈ L1+ with ‖φ‖L1 ≤ r, then G (φ) + c3 (r)φ ∈ L1+.
Theorem 32 Let (H.1)-(H.4) hold and let φ ∈ L1+. The solution l of (2.4)
on [0, Tφ), has the property that l (t) ∈ L1+ for 0 6 t < Tφ.
Furthermore, with one more restriction on the aging and birth functions, the
positive solution exists globally.
Theorem 33 Let (H.1)-(H.4) hold and let φ ∈ L1+, let l be the solution of
(2.4) on [0, Tφ), and let there exist ω ∈ R such that for 0 ≤ t < Tφ, F and G
satisfy the following inequality:
(F (l))(t) +
∫ M
0
G (l (t))(a) da 6 ω
∫ M
0
l (t)(a) da (H.5)
Then Tφ =∞ and ‖l (t)‖L1 ≤ eωt‖φ‖L1 .
4 Basic Theory of the Logistic Age-Dependent Epidemic Model
We will continue investigating the solutions of the specific age-dependent prob-
lem (2.2) in the sense of (2.4). First, specify the birth and aging functions:
(P.1) The aging function G : L1 → L1 is, for φ ∈ L1,
G (φ)(a) = −µ (a)φ (a)− T (φ)φ (a).
(P.2) The birth function F : CT → C ([0,∞] ;R) is, for l ∈ CT ,
(F (l))(t) := S0B (l (t)) e−
∫ t
0
B(l(s))+Q(l(s))ds.
where µ and S0 are as in (2.1), T , B, and Q are as in (A.1)-(A.3).
Theorem 41 Let (A.1), (A.2) and (A.3) hold, let µ ∈ L∞+ [0,M], S0 > 0,
and φ ∈ L1+ [0,M]. There is a function l ∈ C
(
[0,∞) ;L1+
)
such that l is the
unique global solution of (2.4) with the aging function G and birth function F
in (P.1) and (P.2).
For computational convenience and the proof of the asymptotic behavior, we
introduce a solution formula in the following two theorems.
Proposition 42 Let (A.1), (A.2) and (A.3) hold, let µ ∈ L∞+ [0,M], S0 > 0,
and φ ∈ L1+. There exists u ∈ C
(
[0,∞] ;L1+
)
such that u satisfies:
u(t)(a) =
{
(H (u))(t− a) e−
∫ a
0
µ(b)db, a < t
φ (a− t) e−
∫ a
a−t µ(b)db, a ≥ t (4.1)
where
(H (u))(t) =S0B
(
u (t)
1 +
∫ t
0
T (u (s)) ds
)
×
(
1 +
∫ t
0
T (u (s)) ds
)
×
e
− ∫ t
0
B
(
u(s)
1+
∫ s
0 T (u(τ))dτ
)
+Q
(
u(s)
1+
∫ s
0 T (u(τ))dτ
)
ds
Moreover, u is a solution of (2.4) with birth function H and aging function
P : L1 → L1, where P (l)(a) = −µ (a) l (a) for l ∈ L1.
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Theorem 43 Let (A.1), (A.2), and (A.3) hold, let µ ∈ L∞+ [0,M], S0 > 0,
and φ ∈ L1+. Let u ∈ C
(
[0,∞) ;L1+
)
be the solution to the integral equation
(4.1). Then
l (t)(a) =
u (t)(a)
1 +
t∫
0
T (u(τ))dτ
(4.2)
gives the unique global solution l ∈ C ([0,∞) ;L1+)to problem (2.2).
By formula (4.2), we will be able to investigate the asymptotic behaviour of
the solution to (2.2) as in the next theorem. Furthermore, (4.2) also provides
a starting point for our simulations.
Theorem 44 Let (A.1), (A.2) and (A.3) hold, let µ ∈ L∞+ [0,M], S0 > 0,
and φ ∈ L1+. Assume that there is an a0 ∈ [0,M) such that µ (a) > µ0 > 0 for
all a ∈ [a0,M]. Then, for the unique solution of (2.1) in the sense of (2.4),
lim
t→∞S (t) = S∞ > 0, limt→∞ I (t) = limt→∞
∫M
0
i (a, t) da = 0.
5 Application I: Smallpox
Smallpox was eradicated in 1979, but fears of bioterrorist attacks by deliber-
ately releasing the variola virus have been taken into consideration according
to federal and academic observations ever since the terrorist attacks of Septem-
ber 11, 2001. Although the two government laboratories in the United States
and Russia are the only known places that keep the viral samples, the pos-
sibility of other sources cannot be ruled out (CIDRAP 2002). Public health
authorities have detailed plans for emergency preparedness and response to
a smallpox outbreak (CDC 2003); on the other hand, the proper amount of
vaccine and treatment medicine that should be stockpiled is still controversial
(NewYorkTimes 2013).
Due to the undesirable side-effects of the vaccine, the routine vaccination
for the variola virus has been discontinued ever since 1972 and currently the
vaccination is only given to selected military personnel and laboratory workers
who handle the virus. Moreover, because of the waning immunity of the vac-
cine, the proportion of Americans who are both over age 40 and still immune
to smallpox might be too small to achieve herd immunity. As a result based
on the stated concerns, public health authorities, such as Centers for Disease
Control and Prevention (CDC), suggest intensive surveillance and identifica-
tion of infected cases, isolation of smallpox patients, and vaccination of close
contacts of infected individuals. In subsections 5.1-5.4, we compare the effec-
tiveness of two major post-event vaccination strategies: ring vaccination and
mass vaccination, in response of a hypothetical bioterrorist smallpox attack in
a big city. In subsection 5.5, we assess how efficacies of the control strategies
affect the result of ring vaccination.
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5.1 Ring Vaccination
Also known as surveillance and containment, ring vaccination consists of rapid
identification, isolation, vaccination of close contacts of infected persons (pri-
mary contacts), and vaccination of contacts of the primary contact (secondary
contacts). We assume that each identified individual will be asked to provide
a list of contacts of an average number (denoted by CT as in the following
text). Contacts that are successfully traced will be vaccinated and put under
surveillance for a certain quarantine period. That is, vaccination and surveil-
lance are follow-up procedures of tracing, and are applied to both susceptible
contacts (who are in the quarantine class) and infected contacts (who are in
the contact tracing class). We divide the population at time t into seven classes
as shown in a flow diagram in Fig. 1.
S(t)
susceptible
E(t)
exposed
I(t)
infectious
RI(t)
isolated due
to symptoms
R(t)
recovered
TS(t)
traced, vaccinated and
under surveillance
TV (t)
traced, vaccinated and
under surveillance
Fig. 1: Susceptible individuals may become infected, immediately enter the exposed class, E(t), in
which they are not yet infectious, and then enter the infectious class, I(t). Symptomatic infectives
in I(t) may exit to the isolated class, RI(t), and they will recover, enter R(t), and do not return to
S(t) because of immunity. Susceptible people may be traced, vaccinated, put under surveillance,
and they do not return to S(t) because of vaccination. Exposed and infected individuals may
be traced, vaccinated, put under surveillance, and then isolated when they become symptomatic.
There is a possibility for infectious individuals who are neither identified due to symptoms or
isolated by contact tracing, to enter class R(t) when they reach the maximum disease age.
In the following context, we denote Ti as the length of the pre infectious
period (infectiousness threshold), Ts as the length of the pre symptomatic
period (symptoms threshold), and Fi as the length of the infectious period.
Hence Ti + Fi represents the maximum disease age. We consider problem
(2.1) with the same notations. Notice that the dynamics of 4 compartments
illustrated in Fig. 1 depend on S(t) and i (a, t), since E (t) =
∫ Ti
0
i (a, t) da,
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I (t) =
∫ Ti+Fi
Ti
i (a, t) da. Moreover, we have
dR(t)
dt
+
dRI(t)
dt
+
dTS(t)
dt
+
dTV (t)
dt
= i (Ti + Fi, t)︸ ︷︷ ︸
recovery rate of
unidentified infectives
+
∫ Ti+Fi
Ts
µ (a)i (a, t)da︸ ︷︷ ︸
isolation rate of
symptomatic cases
+ T (i (·, t))(E(t)+I(t))︸ ︷︷ ︸
tracing and surveillance
rate of infectives
+ Q(i (·, t))S(t)︸ ︷︷ ︸
tracing and vaccination
rate of susceptibles
Since tracing is a consequence of identifying symptomatic cases, then the
number of contacts traced should be related to the number of infectious cases
identified. Then we assume, for simplicity, that the tracing (hence vaccinating
and surveilling) rate is proportional to the isolation (identifying new cases)
rate. That is, in model (2.1), we set
T (i (·, t)) = ηI · CT
S0
∫ Ti+Fi
Ts
µ (a) i (a, t) da
Q(i (·, t)) = ηS · CT
S0
∫ Ti+Fi
Ts
µ (a) i (a, t) da
B(i (·, t)) =
∫ Ti+Fi
Ti
β (a) i (a, t) da
(5.1)
where µ(a) is the isolation removal rate for symptomatic infectives at disease
age a as in (2.1), β(a) is the disease transmission rate of an infectious individ-
ual at disease age a, CT is the average number of contacts provided by each
identified infective, S0 is the initial susceptible population as in (2.1), and ηI
and ηS are proportionality constants for tracing the infected class and the
susceptible class, respectively. Discussions about meanings and estimations of
the parameters ηI and ηS are in the following context.
Contacts provided by an identified infective may come from any of the
seven classes in Fig. 1, but only those who are in the classes S(t), E(t), and
I(t) may be successfully traced, vaccinated, and put under surveillance. We
assume that the probability for a contact being infected (or susceptible) at time
t is proportional to the density of the infected (susceptible) population at time
t, and we take ηI(ηS) to be the constants of proportionality, respectively. Then
at time t, the rate of tracing infected individuals is:
ηI
E (t) + I (t)
S0︸ ︷︷ ︸
probability of tracing an infected contact
· CT
︸ ︷︷ ︸
average number of infected contacts
traced per identified symptomatic case
·
(∫ Ti+Fi
Ts
µ (a) i (a, t) da
)
︸ ︷︷ ︸
rate of identifying symptomatic cases
(5.2)
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The rate of tracing susceptible individuals is:
ηS
S (t)
S0︸ ︷︷ ︸
probability of tracing
a susceptible contact
· CT
︸ ︷︷ ︸
average number of susceptible contacts
traced per identified symptomatic case
·
(∫ Ti+Fi
Ts
µ (a) i (a, t) da
)
︸ ︷︷ ︸
rate of identifying symptomatic cases
(5.3)
which are exactly the corresponding terms in (2.1) with the setting (5.1).
Moreover, the probability interpretations in (5.2) and (5.3) imply that for any
time t, ηI and ηS should satisfy:
ηI
E (t) + I (t)
S0
+ ηS
S (t)
S0
6 1 (5.4)
We denote the probability that a traced contact of an identified symp-
tomatic individual is infected as η, a parameter that describes the tracing
efficacy in finding infectives. Hence ηI and ηS can be obtained when the value
of η is given: ηI = η
S0
E(t)+I(t) from (5.2), and ηS 6 (1− η) S0S(t) by (5.3). Since
S(t) is mostly unchanged for t in the initial phase of the outbreak, for simplic-
ity, we take S0S(t) ≈ 1 and S0E(t)+I(t) ≈ S0E(0)+I(0) for any time t. So ηI and ηS are
estimated by η and the initial conditions, i.e., ηI = η
S0
E(0)+I(0) and ηS 6 1−η.
The value of η can be easily determined from evolving data during the initial
phase of the epidemic: it is simply the fraction of the traced contacts who turn
out to be symptomatic over all traced contacts.
In particular, when ηI = ηS = 1, then the probability of tracing an infected
contact at time t is η = E(t)+I(t)S0 and that of tracing a susceptible contact at
time t is S(t)S0 . That means the probability of tracing an infected (susceptible)
contact at time t is exactly the fraction of infected (susceptible) population at
time t, which indicates that the tracing is random and is not effective.
5.2 Mass Vaccination
Mass vaccination, usually conducted at a constant rate, is the strategy of vacci-
nating large numbers of people. We assume that there is no residual immunity
in the population, and a post-event mass vaccination, together with a strategy
of isolating symptomatic individuals, start as soon as the first case is identi-
fied. We consider the fact that infected people vaccinated in the first few days
of exposure will not transmit smallpox to others (CDC 2004). And we denote
Tv as the length of vaccine sensitive period for infectives, that is, infectives
receive vaccination with disease age less than Tv will not be infectious. This
assumption is not relevant in ring vaccination: infected contacts at any disease
age are removed due to vaccination and surveillance, hence Tv is a parameter
that only used in mass vaccination. Fig. 2 shows the dynamic of the disease
transmission with mass vaccination.
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S(t)
susceptible
Ev(t)
exposed
Eu(t)
exposed
I(t)
infectious
RI(t)
isolated due
to symptoms
R(t)
recovered
V (t)
successfully
vaccinated
Fig. 2: Ev(t) denotes the number of infectives in the vaccine sensitive stage, so they will not
transmit the disease to others if vaccinated. Eu(t) denotes the number of infectives in the vaccine
insensitive stage, who will be able to transmit the disease even after vaccination.
The following mass vaccination model is of a simpler form than (2.1), which
can be analyzed by the method in (Webb et al 2010).
∂
∂t
i (a, t) +
∂
∂a
i (a, t) = −µ (a) i (a, t)− ν (a) i (a, t) , 0 6 a 6 Ti + Fi, t > 0
d
dt
S (t) = −
(∫ Ti+Fi
Ti
β (a) i (a, t) da
)
S (t)− ν0S (t) , t > 0
i (0, t) =
(∫ Ti+Fi
Ti
β (a) i (a, t) da
)
S (t) , t > 0
i (a, 0) = i0 (a) , 0 6 a 6 Ti + Fi, S (0) = S0
(5.5)
where ν (a) is the mass vaccination removal rate of infected individuals at
disease age a, ν0 is the mass vaccination rate, and the other notations have
the same interpretations as in the ring vaccination model.
5.3 Model Parameters
Table 1 describes smallpox natural history and Table 2 shows parameter val-
ues/ranges we choose for simulations. We pick the threshold values of Ti, Ts
and Fi as recommended in (Eichner 2003) and (CDC 2004). Fig. 3a illustrates
the transmission rate function of disease age, the shape of the function sug-
gested in studies (Aldis and Roberts 2005; Carrat et al 2008; Eichner 2003;
CDC 2004), and (Valle et al 2005), and we make a theoretical estimation
about the value of the transmission rate. We vary Rsym, the percentage of
symptomatic individuals removed per day, from 50% to 90%, which is an es-
timation of an efficient removal process of smallpox due to its identifiable
symptoms after the prodrome.
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We model a deliberate release of smallpox pathogen in a big city as large as
New York, which has a total population of 8× 106. All of the simulations start
with an age distribution of index cases as shown in Fig. 3b, which corresponds
to a scenario when one or several public places encounter a series of smallpox
virus releases.
Table 1. Smallpox durations of the progression stages.
Stage Duration Infectiousness References
Incubation period 7 ∼ 17 days Not infectious (CDC 2004)
Initial symptoms(prodrome) 2 ∼ 4 days Sometimes infectious (CDC 2004)
Early rash 4 days Most infectious (CDC 2004)
Pustular rash and scabs 16 days Infectious (CDC 2004)
Scabs resolved Not infectious (CDC 2004)
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(a) Infection transmission rate function β (b) Initial disease-age distribution func-
tion i0
Fig. 3: Fig. 3a is the infection age-dependent transmission rate function with respect to age
since infection. Ti, Ts, and Fi are introduced and estimated as in the context and Table 2. The
grey area is the prodromal period with initial symptoms and early contagiousness. Fig. 3b is the
initial disease distribution function i0.
5.4 Simulations of Different Vaccination Strategies: Mass Vaccination versus
Ring Vaccination
There are two ring vaccination scenarios in Fig. 4: the green curves represent
an effective ring vaccination strategy, and the blue curves represent an inef-
fective ring vaccination strategy when ηI = ηS = 1. We observe pulses in the
daily number of traced and vaccinated contacts in both of the two scenarios.
These pulses are caused by the choice of the initial infection-age distribution
function in Fig. 3b. The majority of the index cases are in an early disease
age, and thus they will become infectious and symptomatic in the same time
period. As a consequence, symptomatic cases and generations of new cases
will appear as pulses; hence daily traced contacts will appear as pulses, since
the tracing rate depends on the isolation rate of symptomatic cases.
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Table 2. Baseline parameters and initial conditions.
Parameter descrip-
tion
Parameter baseline value References
infectiousness
threshold
Ti = 12 days (Eichner 2003)
symptoms thresh-
old
Ts = 14 days (CDC 2004; Eichner
2003)
vaccine insensitive-
ness threshold†
Tv = 3 days (CDC 2004)
length of infectious
period
Fi = 28 days (CDC 2004)
infection transmis-
sion rate function
β (a) =

0 , 0 6 a < 12
2.5 · 10−8(a− 12)2e−0.5(a−12),
12 6 a 6 40
Fig. 3a
removal of symp-
tomatic cases
Rsym > 50% per day (Webb et al 2010;
Meltzer et al 2001)
isolation rate of in-
fectives
µ (a) =
{
0.0, a 6 14
− ln (1.0−Rsym) , a > 14 (Webb et al 2010)
mass vaccination
removal rate of
infectives†
ν (a) =
{
ν0, 0 6 a 6 3
0, a > 3
(CDC 2004)
mass vaccination
rate†
0 6 ν0 6 10000 (Kaplan et al 2003)
average number of
contacts traced per
identified case∗
0 < CT 6 100 (Kaplan et al 2003)
probability for
a traced contact
being infected∗
0 < η 6 1 Text
initial susceptible
population
S0 = 8× 106 Text
index cases distri-
bution
i0 ∈ L1+ [0, Ti + Fi] Fig. 3b
∗parameters only used in ring vaccination.
†parameters only used in mass vaccination.
Fig. 4 also gives comparison between ring and mass vaccination strate-
gies from different aspects: (1) the effective ring vaccination strategy prevents
the most cases from occurring and requires less personnel and less vaccine
stockpiles; (2) the effective ring vaccination strategy does not require a large
number of people to be traced everyday, and is more efficient in controlling
the outbreak compared to the mass vaccination (red curves), which requires
vaccination of a large number of people everyday; (3) the ineffective ring vac-
cination has similar results in controlling the outbreak as the mass vaccination
(red curves), even though it consumes less vaccine stockpiles in total; it re-
quires extremely heavy daily contact tracing load at times; (4) compared with
the case of no vaccination (black curves), mass vaccination and ineffective ring
vaccination prevent hundreds of cases from happening; (5) further simulations
show that, for higher Rsym values, non-vaccination could control the spread of
smallpox as well as mass vaccination and ineffective ring vaccination, while in
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Fig. 4: There are four different cases included in this figure. The green curves stand for the
case with effective ring vaccination when CT = 50, Rsym = 50%, and η = 0.1. The blue curves
represent the case with ineffective ring vaccination when CT = 50, Rsym = 50%, and ηI = ηS = 1,
so η =
I(t)+E(t)
S0
. The red curves are for the case with mass vaccination when Rsym = 50% and
the mass vaccination rate is 4000 individuals per day. The black curves correspond to the case
with an isolation removal rate of Rsym = 50% but no vaccination.
contrast effective ring vaccination attains significant improvement in reducing
total number of cases.
We also take into consideration the fact that tracing, vaccinating, and
surveilling a contact in ring vaccination demands a different level of personnel
effort than in mass vaccination. So in Fig. 5, we compare an effective ring
vaccination of a highest daily contact tracing rate of 4, 000 contacts per day,
with a mass vaccination of a constant daily vaccination rate of 12, 000 people
per day. That is, we assume that tracing, vaccinating, and surveilling a contact
requires three times more effort than the comparable mass vaccination effort.
As can be seen from the simulation, the effective ring vaccination prevents more
cases, and vaccinates less people than the mass vaccination, which would also
help reduce serious vaccination side effects.
5.5 Simulations of Ring Vaccination: Assessing Impacts of Parameters
In order to provide guidance to public health authorities for containment and
surveillance strategies, we vary the three variables, CT , η, and Rsym, to assess
different levels of ring vaccination by evaluating: (1) total number of infected
cases, and (2) the percentage of traced individuals.
The simulation results in Fig. 6 are intuitively reasonable: for fixed CT =
50, high efficacies of both isolation and contact tracing will prevent more cases
and save more personnel engaged in tracing. Increasing η enables us to trace
more infected contacts per identified case, and it in turn saves personnel efforts.
Modeling of Contact Tracing in Epidemic Populations Structured by Disease Age 15
Fig. 5: The green curves stand for the case of an effective ring vaccination when CT = 50,
Rsym = 50%, and η = 0.1. The red curves are for the case of mass vaccination when Rsym = 50%
and the mass vaccination rate is 1, 2000 individuals per day.
total number of cases % of people traced
Fig. 6: The blue surface is the total number of cases as a function of daily removal percentage of
symptomatic cases 50% 6 Rsym 6 90%, and the probability that a traced contact of an identified
symptomatic individual is infected 0 < η 6 0.6. The number of contacts traced per identified case
is CT = 50. The green surface is the percentage of contact traced individuals as a function of the
same variables under the same settings.
When the values of η and Rsym are relatively small, increasing either one of
them is efficient in both controlling the outbreak and relieving the burden of
tracing. If we are already able to maintain the isolation and contact tracing at
a relatively high level, increasing either of the two levels would require more
personnel to be involved, but just improve the results slightly.
We fix η = 0.1 in Fig. 7, and notice that raising the value of CT does help
reduce the total number of cases, but it also boosts the demand for the num-
ber of health care workers engaged in tracing, vaccinating, and surveilling. For
fixed value of η, increasing CT helps reduce infections in two ways: increas-
ing the number of infected contacts traced per identified case; and increasing
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total number of cases % of people traced
Fig. 7: The blue surface is total number of infected cases as a function of daily removal percentage
of symptomatic cases 50% 6 Rsym 6 90%, and the average number of contacts traced per
identified case 10 6 CT 6 100. The probability for tracing an infected contact is fixed as we take
η = 0.1. The green surface is the percentage of contact traced population as a function of the
same variables under the same settings.
total number of cases % of people traced
Fig. 8: The blue surface is attack ratio as a function of the probability that a traced contact of
an identified symptomatic individual is infected 0 < η 6 0.6, and the number of contacts traced
per identified case 10 6 CT 6 100. The daily removal percentage of symptomatic cases is fixed
as Rsym = 60%. The green surface is the percentage of contact traced population as a function
of the same variables under the same settings.
the number of susceptible contacts quarantined which results in lower infection
rates. Since large values of CT and Rsym require more public health resources,
it is left to the public health officials to determine appropriate levels of contact
tracing and isolation. In the case when an effective vaccination is absent, we
do not expect to quarantine a great amount of susceptibles, so the decision of
increasing CT should be carefully made.
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In Fig. 8, we assume that the removal percentage of symptomatic cases is
fixed as 60%. CT and η represent different aspects of ring vaccination strategy,
and this simulation suggests how to deploy resources assigned in tracing and
control the outbreak in a more economical way. In contrast to Fig. 7, when
contact tracing is of higher efficacy in finding infected contacts, increasing the
average number of contacts provided by each identified symptomatic case does
not boost greatly the demand for personnel and vaccine stockpiles. So under
the assumption that the tracing efficiency η can be maintained while CT is
increased, tracing more contacts per case will help prevent cases and will not
result in much more tracing work.
6 Application II: Influenzas: SARS
In this section, we apply our model to investigate contact tracing effectiveness
in control of modern influenzas and take the outbreak of SARS (severe acute
respiratory syndrome) as an example. First, we use our model to simulate the
SARS outbreak in Taiwan, 2003 by real data. Then we modify the length of
presymptomatic period hypothetically in order to provide suggestions about
the efficacy of contact tracing under different circumstances.
Distinct from smallpox, the conduct of surveillance and control strategies
of modern influenzas (such as H1N1 and SARS) is less efficient due to the lack
of timely vaccines, non-compliance of the public with quarantine, and period of
asymptomatic infectiousness. It is widely believed that SARS was eradicated
because of limited transmission occurring before symptom onset, but the ef-
fectiveness of contact tracing is still controversial even in the regions where
high levels of contact tracing were conducted, such as Taiwan and mainland
China. We apply our model to simulate the SARS outbreak in Taiwan, 2003,
concentrated in the Taipei-Keelung metropolitan area (with a population of 6
million in 2003), because of the extensive available data and the high efficiency
of contact tracing in Taiwan.
6.1 Parameters
In Table 3, we list the parameters that are obtained from real data (MMWR
2003) and clinical studies of SARS. In (MMWR 2003), we count the total
number of traced close contacts as 12, 394. Of those there are only 33 confirmed
to be infected. In this way we set η ≈ 33/12394 and CT ≈ 12394/300, where
300 is approximately the total number of cases in Taipei-Keelung metropolitan
area (which we refer to Taipei area for short in the following context). The
setting of the baseline values has three uncertain aspects: (1) Ts−Ti determines
the length of the incubation period: we set that to be 1.0 day in the data fitting
in subsection 6.2. (2) We make an assumption of the shape of transmission rate
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function β based on laboratory diagnosis of SARS (Carrat et al 2008; Peiris
and et al. 2003; Chan and et al. 2004), and determine its value by estimating
the basic reproduction number of SARS in Taiwan as about 4.8 (Hsieh et al
2004; Bauch et al 2005). (3) We estimate the shape of the removal rate function
of symptomatic individuals µ by comparing it to studies (Gumel et al 2004;
Nishiura et al 2004; Carrat et al 2008). We estimate the maximal value of µ
in Fig. 9b by fitting data of SARS in the Taipei area.
Table 3. Baseline Parameters
Parameter description Baseline values References
infectiousness threshold Ti = 5.0 days (Meltzer 2004; Hsu and et al.
2003)
symptoms threshold Ts = 6.0 days (Meltzer 2004; Hsu and et al.
2003)
length of infectious period Fi = 21.0 days (Meltzer 2004; Hsu and et al.
2003)
isolation rate of infectives Fig. 9b (Gumel et al 2004; Nishiura et al
2004)
infection transmission rate
function
Fig. 9a (Hsieh et al 2004; Bauch et al
2005; Carrat et al 2008; Peiris
and et al. 2003; Chan and et al.
2004)
average number of contacts
traced per identified case
CT ≈ 12394/300 (MMWR 2003)
probability for a traced contact
being infected
η ≈ 33/12394 (MMWR 2003)
initial susceptible population S0 = 6× 106 Text
index cases distribution Fig. 9c (Hsieh et al 2004; MMWR 2003)
(a) Infection transmission
rate function β
(b) Removal rate function µ (c) Initial disease age distri-
bution i0
Fig. 9: The β, µ, and i0 functions we use to fit the SARS data in Taiwan, 2003.
6.2 Data Fitting
Our simulation results are shown in Fig. 10. Compared to simply using iso-
lation of symptomatic cases, enforced contact tracing can help prevent 40
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individuals from being infected. That means contact tracing and quarantine
of more than 12, 000 people in the Taipei area enabled public health officials
to discover 33 infected cases, and thus about 7 cases were avoided.
Fig. 10: The blue dots are the real data from the SARS outbreak in Taipei-Keelung metropolitan
area, 2003. The green curves represent our simulation to fit the real data with parameters in Table
3. The red curves stand for the assumption that there is only isolation of symptomatic cases but
no contact tracing implemented.
6.3 Alternative Fitting Parameters
In Fig. 11, we modify two of the uncertain parameters mentioned before, the
length of presymptomatic period Ts−Ti and the removal rate of symptomatic
infectives (which is the highest value of the removal rate function µ), and fit the
data from Taiwan SARS. As can be inferred from Fig. 11, longer incubation
period requires higher efficiency of symptomatic case isolation in order to
maintain the total number of cases at the same level. As a consequent result,
we observe that the number of cases that are avoided by contact tracing under
all pairs of parameters in Fig. 11 is as much as 40. Which means, we can
assess the effectiveness of contact tracing in SARS, Taiwan without an accurate
estimation of the incubation period since different assumptions lead to similar
results.
7 Discussion
We introduce a general epidemic model that takes age since infection into
consideration, to model interventions such as contact tracing, quarantine, and
vaccination. Our model is applicable to different control strategies that can
be formulated consistent with the hypotheses (A.1) − (A.3). The global ex-
istence, uniqueness, and asymptotic behaviour of solutions are proved in the
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Fig. 11: The blue curve stands
for pairs of parameters, incuba-
tion period length Ts − Ti and
maximum removal rate of symp-
tomatic infectives, that can be
applied in our model in order to
fit the outbreak data of SARS,
Taipei area. The red dot is the
pair of parameter we used in
the data fitting Fig. 10. Fur-
ther simulation indicates that
the number of cases that are
avoided by contact tracing re-
mains the same no matter which
pair of the parameters we take.
appendix. The theoretical results in Section 3 are true for non-linear age-
dependent models with aging and birth functions satisfying (H.1) and (H.2),
where (H.2) applies to different conditions than that in (Webb 1985). Com-
pared to previous models with infection age as a continuous variable, we are
able to incorporate some important aspects of the spread and control of an
epidemic disease in the model, together with practical interpretations of the
corresponding parameters. For example, (i) by considering the simplified fact
that the tracing rate varies according to case identification rate, we will be able
to understand one of the reasons for small fluctuations that usually appear in
daily cases in many of the real data; (ii) decrease of susceptible population
due to public health interventions is not negligible when the interventions suc-
cessfully protect a considerable amount of people from infection.
In application I, we use our model to assess public health guidelines in the
event of a smallpox bioterrorist attack in a large urban center. Our simulation
falls into the scenario that releases of the virus take place in the commu-
nity with people being unaware of them. But we can easily modify the initial
conditions to simulate other initial scenarios, such as when index cases are in-
troduced into the community by a smallpox release in another area, while the
government and the public are getting prepared and in a watchful state. Our
simulation results point out that with a limited amount of vaccine stockpiles
and healthcare workers, ring vaccination is more efficient in preventing the dis-
ease from spreading than mass vaccination. With the initial condition in Fig.
3b, there are not many people in the vaccination queue at the beginning of the
outbreak. In this case, ring vaccination allows the early vaccine distribution
for selected groups to enhance the response readiness (CDC 2003), and hence
allows more efficient utilization of vaccination capacity.
We also investigate the ring vaccination effectiveness by varying the three
key parameters: isolation rate, contacts traced per case, and contact tracing
efficiency in finding infectives. Fig. 6 and Fig. 7 also confirm the conclusion
in (Day et al 2006): tracing and quarantine help avert more cases when the
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isolation of symptomatic cases is ineffective. Additionally, we show that in the
case of smallpox, the effectiveness of ring vaccination in reducing infections
increases at an accelerating rate as the effectiveness of isolation diminishes2
when the ring vaccination efficacy is of a normal level, but it increases at an al-
most constant lower rate when the ring vaccination efficacy is of a higher level.
Our model is able to provide guidance to public health decisions to adjust
current contact tracing strategies either before or during an outbreak with
updated data. All the parameters in our model have good epidemiological
interpretations and are easy to estimate with data from historical epidemic
outbreaks. Unlike many other studies, we take into consideration susceptible
population variation due to quarantine and vaccination, which usually leads
to community herd immunity. So when vaccines are available, our model can
be applied to provide guidelines for vaccination strategies to create herd im-
munity3.
In application II, we show that our simulation of SARS in Taiwan fits
well with the observed data, and we are able to answer the question about
how many cases are avoided by implementing contact tracing and quarantine
in the control of the outbreak. With more precise data about each identified
case, we would be able to estimate the case isolation rate accurately, and our
model would enable us to determine the length of incubation period by data
fitting. Therefore, our model would also be helpful in estimating important
parameters and predicting transmission dynamics with evolving data during
an outbreak. A great difference between the two applications we present in the
paper is, contact tracing applied to control SARS in Taiwan, 2003 is not as
effective as ring vaccination strategy in eradicating smallpox. The theoretical
reason is that we have different settings of contact tracing parameters CT , ηI ,
and ηS in the two applications. In reality, our settings are quite reasonable
due to facts such as the severity of symptoms, availability of vaccines (since
vaccination is an important way to create herd immunity), and readiness of
the public health officials with the preparedness and containment plans.
Our simulations can guide public health officials in adjusting levels of dif-
ferent strategies to control the outbreak and deploy resources efficiently. With
theoretical suggestions, realistic adjustments about how to deploy limited re-
sources (such as vaccine stockpiles, healthcare workers, surveillance stations,
etc.) to meet the theoretical levels would strongly depend on the decisions of
public health authorities. Furthermore, with cost-effectiveness data, we can
apply optimal control methods to quantitatively determine the best control
strategies.
2 Quote from (Day et al 2006)
3 A historical example is the ”ring” vaccination strategy used to eliminate smallpox
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Furthermore, the age-structured model possesses great potential in model-
ing the vaccination strategy of HIV (although the HIV vaccine does not exist so
far, several encouraging studies such as (Hansen and et al. 2013) suggest that
there is a significant hope in the future). The HIV infection has an extremely
long asymptomatic period and many HIV-positive people are unaware of their
infection with the virus. Thus, an active infected individual would spread the
disease without even being aware of the infection, which makes the control
and detection of HIV very difficult. Even though we might have an HIV vac-
cine available in the future, with possible serious side-effects, it might be too
limited and costly to be available to everyone at the beginning. So the de-
ployment of a limited amount of vaccine will be a serious issue. Then, because
of the prolonged asymptomatic stage of HIV infection, the effects of certain
intervention strategies would depend even more on the age of infection. Our
model will be an advantageous starting point for such investigation.
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8 Appendix
Theorem 31 can be proved by the following three propositions:
Proposition 81 Let (H.1), (H.2) hold, let T > 0, let φ ∈ L1, and let l ∈ CT .
If l is a solution of the integral equation:
l (t) (a) =
{
(F (l)) (t− a) + ∫ t
t−aG (l (s)) (s+ a− t) ds, 0 < a < t
φ (a− t) + ∫ t
0
G (l (s)) (s+ a− t) ds, t ≤ a ≤ M (8.1)
on [0, T ], then l is a solution of (2.4) on [0, T ].
Proof The proof is similar to that of Proposition 2.1 in (Webb 1985), except
that we can use the uniform continuity of the function t 7→ (F (l)) (t) from
[0, T ] to R for l ∈ CT instead in this proof.
Proposition 82 Let (H.1), (H.2) hold and let r > 0. There exists T > 0 such
that if φ ∈ L1 and ‖φ‖L1 ≤ r, then there is a unique function l ∈ CT such that
l is a solution of (8.1) on [0, T ].
Proof We will prove it by contraction mapping theorem. We fix r > ‖φ‖L1 > 0
and choose T > 0 such that
T ·
c1 (2r) + c2 (2r, T ) + sup0≤t≤T |(F (0)) (t)|+ ‖G (0)‖L1
2r
 ≤ 1
2
Then define S as a closed subset of CT :
S :=
{
l ∈ CT : l (0) = φ, ‖l‖CT ≤ 2r
}
We define a mapping K on S as following and prove that K is a strict con-
traction from S into S.
(K (l)) (t) (a) =
{
(F (l)) (t− a) + ∫ t
t−aG (l (s)) (s+ a− t) ds, a.e. a ∈ (0, t)
φ (a− t) + ∫ t
0
G (l (s)) (s+ a− t) ds, a.e. a ∈ [t,M]
we need to verify that the following conditions hold:
(i) Let l ∈ S, t ∈ [0, T ], then ‖(K (l)) (t)‖L1 6 2r.
(ii) Let l ∈ S and let 0 ≤ t < tˆ ≤ T , then ∥∥(K (l)) (t)− (K (l)) (tˆ)∥∥
L1
→ 0
as
∣∣tˆ− t∣∣→ 0.
(iii) Let l1, l2 ∈ S, then ‖K (l1)−K (l2)‖CT ≤ 12‖l1 − l2‖CT .
For (i), we will only consider the case when 0 ≤ t ≤ min{M, T}. (Otherwise, we
have t > M > a, then we just need to consider the expression of (K (l)) (t) (a)
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for a ∈ (0, t).)
‖(K (l)) (t)‖L1 =
∫ M
0
|(K (l)) (t) (a)| da
6
∫ t
0
∣∣∣∣(F (l)) (t− a) + ∫ t
t−a
G (l (s)) (s+ a− t) ds
∣∣∣∣ da
+
∫ M
t
∣∣∣∣φ (a− t) + ∫ t
0
G (l (s)) (s+ a− t) ds
∣∣∣∣ da
6
∫ t
0
|(F (l)) (s)| ds+
∫ M−t
0
|φ (s)| ds+
∫ t
0
∫ M
t−s
|G (l (s)) (s+ a− t)| dads
6
∫ t
0
|(F (l)) (s)− (F (0)) (s)| ds+
∫ t
0
|(F (0)) (s)| ds+
∫ M
0
|φ (s)| ds
+
∫ t
0
‖G (l (s))−G (0)‖L1ds+
∫ t
0
‖G (0)‖L1ds
6c2 (2r, t)
∫ t
0
sup
06τ6s
‖l (τ)‖L1ds+ t · sup
06s6t
|(F (0)) (s)|+ ‖φ‖L1
+ c1 (2r)
∫ t
0
‖l (s)‖L1ds+ t · ‖G (0)‖L1
≤2rT
c1 (2r) + c2 (2r, T ) + sup0≤t≤T |(F (0)) (t)|+ ‖G (0)‖L1
2r
+ r ≤ 2r
For (ii), we can just follow the same estimation in the proof of Proposition
2.2 in (Webb 1985), except that we need to use the uniform continuity of the
function t 7→ (F (l)) (t) from [0, T ] to R for l ∈ CT . (i) and (ii) imply that K
maps S into S, (iii) shows that K is a contraction.
To prove (iii), given any l1, l2 ∈ S, we consider 0 ≤ t ≤ min{M, T}. Similarly
we have:∫ M
0
|(K (l1)) (t) (a)− (K (l2)) (t) (a)| da
≤
∫ t
0
|(F (l1)) (s)− (F (l2)) (s)| ds+
∫ t
0
‖G (l1 (s))−G (l2 (s))‖L1ds
≤
∫ t
0
c2 (2r, s) sup
06τ6s
‖l1 (τ)− l2 (τ)‖L1ds+ c1 (2r)
∫ t
0
‖l1 (s)− l2 (s)‖L1ds
≤T · [c1 (2r) + c2 (2r, T )] ‖l1 − l2‖CT ≤
1
2
‖l1 − l2‖CT
Proposition 83 Let (H.1), (H.2) hold, let φ, φˆ ∈ L1, let T > 0, and let
l, lˆ ∈ CT such that l, lˆ is the solution of (2.4) on [0, T ] for φ, φˆ, respectively.
Let r > 0 such that ‖l‖CT ,
∥∥∥lˆ∥∥∥
CT
≤ r. Then for 0 ≤ t ≤ T ,∥∥∥l (t)− lˆ (t)∥∥∥
L1
6 e[c1(r)+c2(r,T )]t
∥∥∥φ− φˆ∥∥∥
L1
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Hence we have the uniqueness of the local solution of (2.4).
Proof For each t ∈ [0, T ] we define two continuous functions:
(1) V (t) :=
∥∥∥l (t)− lˆ (t)∥∥∥
L1
=
∫M−t
−t
∣∣∣l (t) (t+ c)− lˆ (t) (t+ c)∣∣∣ dc
(2) W (t) := sup
06s6t
∥∥∥l (s)− lˆ (s)∥∥∥
L1
= sup
06s6t
V (s)
Next, we estimate lim sup
h→0+
h−1 [W (t+ h)−W (t)] for each fixed t ∈ [0, T ] sep-
arately under the following two situations:
(i) V (t) < W (t) (as shown in Fig. 12), i.e., ∃t0 < t such that W (t) =
V (t0) > V (t). Since the mapping s 7→ V (s) is continuous, we can choose
sufficiently small h > 0 such that V (t+ δ) 6 V (t0) for 0 6 δ 6 h, hence
W (t+ δ) = W (t) for 0 6 δ 6 h. Then lim sup
h→0+
h−1 [W (t+ h)−W (t)] =
0.
Fig. 12
(ii) V (t) = W (t), i.e., the function V attains the supremum value in [0, t] at
t. Then we have
h−1 [W (t+ h)−W (t)] = h−1
[
sup
06s6t+h
V (s)− V (t)
]
=h−1
[
max
{
V (t) , sup
t≤s≤t+h
V (s)
}
− V (t)
]
≤ h−1
∣∣∣∣ sup
t≤s≤t+h
V (s)− V (t)
∣∣∣∣
≤h−1 sup
t6s6t+h
|V (s)− V (t)| = sup
06h06h
h0
h
h−10 |V (t+ h0)− V (t)|
6 sup
06h06h
h−10 |V (t+ h0)− V (t)|
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For each h0 ∈ [0, h], we estimate
h−10 [V (t+ h0)− V (t)]
=h−10
∫ −t
−t−h0
∣∣∣l (t+ h0) (t+ h0 + c)− lˆ (t+ h0) (t+ h0 + c)∣∣∣ dc
+ h−10
∫ M−t−h0
−t
∣∣∣l (t+ h0) (t+ h0 + c)− lˆ (t+ h0) (t+ h0 + c)∣∣∣ dc
− h−10
∫ M−t
−t
∣∣∣l (t) (t+ c)− lˆ (t) (t+ c)∣∣∣ dc
6h−10
∫ h0
0
|l (t+ h0) (a)− (F (l)) (t)| da
+ h−10
∫ h0
0
∣∣∣(F (l)) (t)− (F (lˆ)) (t)∣∣∣ da
+ h−10
∫ h0
0
∣∣∣(F (lˆ)) (t)− lˆ (t+ h0) (a)∣∣∣ da
+
∫ M
0
∣∣h−10 [l (t+ h0) (a+ h0)− l (t) (a)]−G (l (t)) (a)∣∣ da
+
∫ M
0
∣∣∣G (l (t)) (a)−G(lˆ (t)) (a)∣∣∣ da
+
∫ M
0
∣∣∣h−10 [lˆ (t+ h0) (a+ h0)− lˆ (t) (a)]−G(lˆ (t)) (a)∣∣∣ da
So for both of the above situations, notice that both l and lˆ are solutions of
problem (2.4), we can estimate as the following:
lim sup
h→0+
h−1 [W (t+ h)−W (t)] 6 lim sup
h→0+
sup
06h06h
h−10 |V (t+ h0)− V (t)|
6
∣∣∣(F (l)) (t)− (F (lˆ)) (t)∣∣∣+ ∥∥∥G (l (t))−G(lˆ (t))∥∥∥
L1
6c2 (r, t) sup
06s6t
∥∥∥l (s)− lˆ (s)∥∥∥
L1
+ c1 (r)
∥∥∥l (t)− lˆ (t)∥∥∥
L1
6 [c1 (r) + c2 (r, T )]W (t)
So we have W (t) 6 e[c1(r)+c2(r,T )]tW (0) (Lakshmikantham and Leela 1969,
Theorem 1.4.1). Hence,
V (t) 6W (t) 6 e[c1(r)+c2(r,T )]tW (0) = e[c1(r)+c2(r,T )]t
∥∥∥φ− φˆ∥∥∥
L1
That is, ∥∥∥l (t)− lˆ (t)∥∥∥
L1
6 e[c1(r)+c2(r,T )]t
∥∥∥φ− φˆ∥∥∥
L1
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Proof (Proof of Theorem 32 and Theorem 33) The proof of Theorem 32 and
Theorem 33 are similar to that of the corresponding theorems in Sections
2.3−2.4 in (Webb 1985). We only need to switch the statement of Proposition
2.4 in (Webb 1985) to the following Proposition 84.
Proposition 84 Let (H.1), (H.2) hold, let φ ∈ L1, let T > 0, and let l ∈ CT
such that l is a solution of (8.1) on [0, T ]. Let Tˆ > 0 and let lˆ ∈ CT+T such
that lˆ (t) = l (t) for t ∈ [0, T ], and for t ∈
(
T, T + Tˆ
]
, lˆ satisfies the following
integral equation:
lˆ (t) (a) =

(
F
(
lˆ
))
(t− a) + ∫ t
t−aG
(
lˆ (s)
)
(s+ a− t) ds, 0 < a < t− T
l (T ) (a− t+ T ) + ∫ t
T
G
(
lˆ (s)
)
(s+ a− t) ds, t− T 6 a 6 M
Then lˆ is a solution of (8.1) on
[
0, T + Tˆ
]
.
Proof First of all, we notice that if (H.2) holds, then (F (l)) (t) =
(
F
(
lˆ
))
(t)
for t ∈ [0, T ]. Because for any t ∈ [0, T ], by (H.2), ∃C > 0 such that∣∣∣(F (l)) (t)− (F (lˆ)) (t)∣∣∣ 6 C sup
06s6t
∥∥∥l (s)− lˆ (s)∥∥∥
L1
= 0
Then it is easy to verify that lˆ is a solution to (8.1) for t ∈ [0, T ]. Next, we
verify that lˆ is a solution to (8.1) for t ∈
(
T, T + Tˆ
]
.
For t− T 6 a 6 M:
1. If a > t,
lˆ (t) (a) = l (T ) (a− t+ T ) +
∫ t
T
G
(
lˆ (s)
)
(s+ a− t) ds
= (F (l)) (t− a) +
∫ T
t−a
G (l (s)) (s+ a− t) ds+
∫ t
T
G
(
lˆ (s)
)
(s+ a− t) ds
=
(
F
(
lˆ
))
(t− a) +
∫ t
t−a
G
(
lˆ (s)
)
(s+ a− t) ds
2. If a < t,
lˆ (t) (a) = l (T ) (a− t+ T ) +
∫ t
T
G
(
lˆ (s)
)
(s+ a− t) ds
= φ (a− t) +
∫ T
0
G (l (s)) (s+ a− t) ds+
∫ t
T
G
(
lˆ (s)
)
(s+ a− t) ds
= φ (a− t) +
∫ t
0
G
(
lˆ (s)
)
(s+ a− t) ds
For 0 6 a 6 t− T , the verification is straightforward.
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Proof (Proof of Theorem 41) By Theorem 32 and Theorem 33, We only need
to show that the aging function G in (P.1) and the birth function F in (P.2)
satisfy the hypotheses (H.1)− (H.5). (H.3) and (H.4) are obvious from (P.1)
and (P.2), we will justify (H.1) and (H.2) as follows. First denote µ¯ := ‖µ‖L∞ .
Let r > 0, for any φ1, φ2 ∈ L1 such that ‖φ1‖L1 , ‖φ2‖L1 ≤ r, we have
‖G (φ1)−G (φ2)‖L1
6
∫ M
0
µ (a) |φ1 (a)− φ2 (a)| da+ T (φ1)
∫ M
0
|φ1 (a)− φ2 (a)| da
+ |T (φ1)− T (φ2)|
∫ M
0
|φ2 (a)| da
6 (µ¯+ 2r‖T ‖∞) ‖φ1 − φ2‖L1
so we have (H.1). In order to prove (H.2), first we notice that t 7→ (F (φ)) (t)
is continuous in [0,∞) for any φ ∈ CT . So F : CT → C ([0, T ] ;R).
Next, for any φ1, φ2 ∈ CT such that ‖φ1‖CT , ‖φ2‖CT ≤ r, we have ∀t ∈ [0, T ],
|(F (φ1)) (t)− (F (φ2)) (t)|
≤S0 |B (φ1 (t))− B (φ2 (t))| e−
∫ t
0
B(φ1(s))+Q(φ1(s))ds
+ S0B (φ2 (t))
∣∣∣e− ∫ t0 B(φ1(s))+Q(φ1(s))ds − e− ∫ t0 B(φ2(s))+Q(φ2(s))ds∣∣∣
= : I1 + I2
Obviously, I1 ≤ S0|B|‖φ1 (t)− φ2 (t)‖L1ert(|Q|+|B|).
In order to consider I2, notice that
∣∣eX − eY ∣∣ ≤ eM |X − Y | for |X|, |Y | ≤ M.
Then we have
I2 6 S0|B|rert(|Q|+|B|)
∫ t
0
|B (φ1 (s)) +Q (φ1 (s))− B (φ2 (s))−Q (φ2 (s))| ds
≤S0|B|rert(|Q|+|B|) (|B|+ |Q|)
∫ t
0
‖φ1 (s)− φ2 (s)‖L1ds
Hence,
|(F (φ1)) (t)− (F (φ2)) (t)|
≤S0 |B| ert(|Q|+|B|) [1 + rt (|B|+ |Q|)] sup
06s6t
‖φ1 (s)− φ2 (s)‖L1
Now we let l ∈ C ([0, Tφ) ;L1+) be the positive solution of (2.4), then for any
t ∈ [0, Tφ), (H.5) is easy to verify:
(F (l)) (t) +
∫ M
0
G (l (t)) (a) da 6 S0 |B|
∫ M
0
l (t) (a) da
So by Theorem 33, there is a positive global solution of (2.4).
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Proof (Proof of Proposition 42) Proof of the existence of the global positive
solution is based on the following four lemmas. An easy computation can be
done to testify that a solution of (4.1) is also a solution in the sense of (2.4)
with aging function P and birth function H.
Lemma 85 Let the assumptions in Proposition 42 hold, and let r > 0. There
exists T > 0 such that if ‖φ‖L1 6 r, then there is a unique function u ∈ CT,+
such that u is a solution of (4.1) on [0, T ].
Proof We can choose a sufficiently small T > 0 and define
S :=
{
u ∈ CT,+ : u (t) = φ, ‖u‖CT 6 2r
}
. An argument which is similar to that of Proposition 82 can be used to show
that a mapping defined by (4.1) from S into S is a strict contraction. Thus,
the unique fixed point is a positive solution of (4.1) in CT,+.
Lemma 86 Let the assumptions in Proposition 42 hold, let T > 0, and let
u ∈ CT,+ such that u is a solution of (4.1) on [0, T ]. Let Tˆ > 0 and let
uˆ ∈ CT+Tˆ ,+ such that uˆ (t) = u (t) for t ∈ [0, T ], and for t ∈
(
T, T + Tˆ
]
, uˆ
satisfies the integral equation:
uˆ(t)(a) =
{
(H (uˆ))(t− a) e−
∫ a
0
µ(b)db, 0 < a < t− T
u (T )(a− t+ T ) e−
∫ a
a−t+T µ(b)db, t− T ≤ a ≤ M
where H is as stated in Proposition 42. Then uˆ is a solution of (4.1) on[
0, T + Tˆ
]
.
Proof The proof is similar to that of Proposition 84.
Lemma 87 Let the assumptions in Proposition 42 hold, let φ ∈ L1+, and let u
be the solution of (4.1) on its maximal interval of existence [0, Tφ). If Tφ <∞,
then lim sup
t→Tφ−
‖u (t)‖L1 =∞.
Proof The proof is similar to that of Theorem 2.3 in (Webb 1985).
Lemma 88 Let the assumptions in Proposition 42 hold, let φ ∈ L1+, and let
u be the positive solution of (4.1) on its maximal interval of existence [0, Tφ).
Then ∃ω ∈ R, and for t ∈ [0, Tφ), ‖u (t)‖L1 6 ‖φ‖L1eωt. So Tφ = ∞, there is
a global positive solution of (4.1).
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Proof For t ∈ [0, Tφ), we estimate as follows (here we assume t 6 M, then
t > M leads to a simpler case):
‖u (t)‖L1 =
∫ M
0
u (t)(a) da 6
∫ t
0
(H (u)) (t− a) da+
∫ M
t
φ (a− t) da
6
∫ t
0
S0 |B| ‖u (t− a)‖L1da+
∫ M
t
φ (a− t) da
6S0 |B|
∫ t
0
‖u (s)‖L1ds+
∫ M−t
0
φ (s) ds
6S0 |B|
∫ t
0
‖u (s)‖L1ds+ ‖φ‖L1
Then by Gronwall’s Inequality, we have ‖u (t)‖L1 6 ‖φ‖L1eS0|B|t. Then by
Lemma 87, Tφ =∞, hence there is a positive global solution to (4.1).
Proof (Proof of Theorem 43) Let T > 0, we assume that u ∈ C ([0, T ] ;L1+)
satisfies (4.1) for t ∈ [0, T ], then u satisfies the following conditions:
lim
h→0+
∫ M
0
∣∣h−1 [u (t+ h) (a+ h)− u (t) (a)] + µ (a)u (t) (a)∣∣ da = 0
lim
h→0+
h−1
∫ h
0
|u (t+ h) (a)− (H (u)) (t)| da = 0
u (0) = φ
(8.2)
We will show that l ∈ C ([0, T ] ;L1+) as obtained from (4.2), satisfies (2.4) with
the aging function G in (P.1) and the birth function F in (P.2). For the first
condition in (2.4), we have the following estimation:
h−1 [l (t+ h) (a+ h)− l (t) (a)] + µ (a) l (t) (a) + T (l (t)) l (t) (a)
=
h−1 [u (t+ h) (a+ h)− u (t) (a)] + µ (a)u (t) (a)
1 +
∫ t+h
0
T (u (s)) ds
+
[
µ (a)u (t) (a)
1 +
∫ t
0
T (u (s)) ds
− µ (a)u (t) (a)
1 +
∫ t+h
0
T (u (s)) ds
]
+h−1
[
u (t) (a)
1 +
∫ t+h
0
T (u (s)) ds
− u (t) (a)
1 +
∫ t
0
T (u (s)) ds
]
+
T (u (t))u (t) (a)(
1 +
∫ t
0
T (u (s)) ds
)2
:=I1 + I2 + I3
By (8.2), I1 → 0 as h → 0. I2 → 0 as h → 0 because of the absolute conti-
nuity of Lebesgue integral. If we compute the derivative of function f (t) :=
1
1+
∫ t
0
T (u(s))ds , we get I3 → 0 as h → 0. Hence the first limit in the solution
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definition (2.4) is satisfied. For the second condition in (2.4), we have
∫ h
0
|l (t+ h) (a)− (F (l)) (t)|da
=
∫ h
0
∣∣∣l (t+ h) (a)− S0B (l (t)) e− ∫ t0 B(l(s))+Q(l(s))ds∣∣∣ da
=
∫ h
0
∣∣∣∣∣u (t+ h) (a)− (H (u)) (t)1 + ∫ t
0
T (u (s)) ds
∣∣∣∣∣da→ 0, (h→ 0+)
The third condition in (2.4) is straightforward. Then by Proposition 42, we can
find a u ∈ C ([0,∞) ;L1+) that satisfies (4.1). Then a positive global solution
to problem (2.4) can be obtained by (4.2), which is exactly the unique positive
global solution to (2.4).
Proof (Proof of Theorem 44) Let u ∈ C ([0,∞) ;L1+) be the solution to (4.1),
and let i ∈ C ([0,∞) ;L1+) as defined in (4.2), which is a solution to problem
(2.1) in the sense of (2.4). For convenience in this proof, we use the notation
i (a, t) := i (t)(a) and u (a, t) := u (t)(a), for a ∈ [0,M] , t ∈ [0,∞). Firstly, by
(2.1) we have
S (t) = S0e
− ∫ t
0
B(i(·,s))+Q(i(·,s))ds
which is a positive non-increasing continuous function of t ∈ [0,∞). So lim
t→∞S (t)
exists, and we denote it as lim
t→∞S (t) = S∞ > 0. Next we estimate the follow-
ing:
∫ ∞
0
B (i (·, t)) +Q (i (·, t)) dt 6
∫ ∞
0
(|B|+ |Q|) ‖i (·, t)‖L1dt
= (|B|+ |Q|)
∫ ∞
0
∫ M
0
u (a, t)
1 +
∫ t
0
T (u (·, s)) ds
dadt
= (|B|+ |Q|)
∫ M
0
∫ a
0
φ (a− t) e−
∫ a
a−t µ(b)db
1 +
∫ t
0
T (u (·, s)) ds
dtda
+ (|B|+ |Q|)
∫ M
0
∫ ∞
a
u (0, t− a) e−
∫ a
0
µ(b)db
1 +
∫ t
0
T (u (·, s)) ds
dtda
:= (|B|+ |Q|) (I1 + I2)
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Estimate I1 and I2 separately:
I1 6
∫ M
0
∫ a
0
φ (a− t) e−
∫ a
a−t µ(b)dbdtda =
∫ M
0
∫ a
0
φ (s) e−
∫ a
s
µ(b)dbdsda
=
∫ a0
0
∫ a
0
φ (s) e−
∫ a
s
µ(b)dbdsda+
∫ M
a0
∫ a
0
φ (s) e−
∫ a
s
µ(b)dbdsda
6
∫ a0
0
∫ a
0
φ (s) dsda+
∫ M
a0
∫ a
0
φ (s) e−µ0(a−s)dsda
6a0‖φ‖L1 +
∫ M
0
∫ a
0
φ (s) e−µ0(a−s)dsda
=a0‖φ‖L1 +
∫ M
0
∫ M
s
φ (s) e−µ0(a−s)dads
=a0‖φ‖L1 +
∫ M
0
∫ M−s
0
φ (s) e−µ0τdτds
6a0‖φ‖L1 +
∫ M
0
∫ M
0
φ (s) e−µ0τdτds
=a0‖φ‖L1 +
(∫ M
0
e−µ0τdτ
)
‖φ‖L1 <∞
I2 =
∫ M
0
∫ ∞
a
u (0, t− a) e−
∫ a
0
µ(b)db
1 +
∫ t
0
T (u (·, s)) ds
dtda
6
∫ M
0
∫ ∞
0
u (0, τ) e−
∫ a
0
µ(b)db
1 +
∫ a+τ
0
T (u (·, s)) ds
dτda
6
∫ M
0
∫ ∞
0
u (0, τ) e−
∫ a
0
µ(b)db
1 +
∫ τ
0
T (u (·, s)) dsdτda
=
(∫ ∞
0
i (0, τ) dτ
)(∫ M
0
e−
∫ a
0
µ(b)dbda
)
6
(∫ ∞
0
i (0, τ) dτ
)(
a0 +
∫ M
a0
e−aµ0da
)
With the assumption on function µ, we can find constants C1, C2 > 0 such
that: ∫ ∞
0
B (i (·, t)) +Q (i (·, t)) dt 6 C1 + C2
∫ ∞
0
i (0, t) dt
Since i is obtained from (4.2), we have:
i (0, t) =
u (0, t)
1 +
∫ t
0
T (u (·, s)) ds
= S (t)B (i (·, t))
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Then by the differential equation of S(t) in (2.1), we have:
i (0, t) = −dS (t)
dt
−Q (i (·, t))S (t) 6 −dS (t)
dt
Integrate on both sides with respect to t of the above inequality,∫ ∞
0
i (0, t) dt 6 S0 − S∞ <∞
Hence one of the conclusion is proved:
lim
t→∞S (t) = S0e
− ∫∞
0
B(i(·,s))+Q(i(·,s))ds > S0e−C1−C2
∫∞
0
i(0,t)dt > 0
Moreover, it can be derived from the differential equation system (2.1) that:
S (t) + I (t) +
∫ t
0
Q (i (·, s)) I (s) ds+
∫ t
0
T (i (·, s)) I (s) ds+
∫ t
0
i (M, s) ds
+
∫ t
0
∫ M
0
µ (a) i (a, s) dads = S0 + I (0)
(8.3)
where the four integrals in (8.3) are non-decreasing with respect to the variable
t and have S0 + I (0) as an upper bound. So the four integrals all have finite
limit as t→∞. Then the fact that lim
t→∞S (t) exists implies that limt→∞ I (t)
exists. We can estimate
∫∞
0
I (t) dt =
∫∞
0
‖i (t)‖L1dt similarly as we did in the
beginning of this proof and get
∫∞
0
I (t) dt <∞, which implies the conclusion
lim
t→∞ I (t) = 0.
